Recurrence is currently generally diagnosed by mammogram, ultrasound, biopsies, scans, or blood tests to detect tumor markers.

A personalized mRNA vaccine for melanoma reduced the risk of the cancer returning in a phase III clinical trial, the companies behind the trial announced this week. The vaccine — which relies on the same mRNA technology used to develop COVID-19 shots — is the first mRNA-based cancer treatment to show success in a late-stage trial.

Popular NAD+-boosting supplements like NMN and nicotinamide riboside may shield pancreatic cancer cells from chemotherapy, a new study warns.

New treatments are being explored for glioblastoma and ovarian cancer, incurable and difficult-to-treat cancers.

A multicenter, longitudinal study follows a cohort of women to determine why about 18% experience long-term fatigue.

Adelaide researchers are challenging decades-old assumptions about brain cancer treatment in a bid to make radiation therapy more effective against tumors, while reducing damage to healthy tissue.

Our Lady of the Lake and Mary Bird Perkins Cancer Center have formed a new partnership to provide advanced radiation therapy and artificial intelligence technology to cancer patients in the Baton Rouge area.